The landscape for contract development and manufacturing organisations (CDMOs) has significantly evolved in recent years due to the emergence of new technologies and increased demand for treatments. Contract service providers are therefore adapting the way in which they operate in order to satisfy customer requirements and effectively respond to industry trends and developments.
In recent years, there have been many changes within the pharmaceutical industry that have influenced a surge in demand for CDMOs
In an article with Pharma Network, Jean-Francois Hilaire, Executive Vice President of Strategy and Global Integration at Recipharm explores the key drivers fuelling the surge in demand for CDMO services and future demands that could potentially influence the CDMO sector.